Multicentre validation of a EUCAST method for the antifungal susceptibility testing of microconidia-forming dermatophytes
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Multicentre validation of a EUCAST method for the antifungal susceptibility testing of microconidia-forming dermatophytes
Authors
Keywords
-
Journal
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2020-03-06
DOI
10.1093/jac/dkaa111
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Emerging Terbinafine Resistance in Trichophyton: Clinical Characteristics, Squalene Epoxidase Gene Mutations, and a Reliable EUCAST Method for Detection
- (2019) Ditte M. L. Saunte et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Trichophyton rubrum azole resistance mediated by a new ABC transporter, TruMDR3
- (2019) Michel Monod et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A unique multidrug-resistant clonal Trichophyton population distinct from Trichophytonmentagrophytes / Trichophytoninterdigitale complex causing an ongoing alarming dermatophytosis outbreak in India: genomic insights and resistance profile
- (2019) Ashutosh Singh et al. FUNGAL GENETICS AND BIOLOGY
- A new mutation in the SQLE gene of Trichophyton mentagrophytes associated to terbinafine resistance in a couple with disseminated tinea corporis
- (2019) Aurélie Hsieh et al. JOURNAL DE MYCOLOGIE MEDICALE
- In Vitro Antifungal Activity of Novel Triazole Efinaconazole and Five Comparators against Dermatophyte Isolates
- (2018) Ali Rezaei-Matehkolaei et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Mutation in the Squalene Epoxidase Gene of Trichophyton interdigitale and Trichophyton rubrum Associated with Allylamine Resistance
- (2018) Shivaprakash M. Rudramurthy et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antifungal drug susceptibility profile of clinically important dermatophytes and determination of point mutations in terbinafine-resistant isolates
- (2018) Zahra Salehi et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- A multicentre study of antifungal susceptibility patterns among 350 Candida auris isolates (2009–17) in India: role of the ERG11 and FKS1 genes in azole and echinocandin resistance
- (2018) Anuradha Chowdhary et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- High terbinafine resistance in Trichophyton interdigitale isolates in Delhi, India harbouring mutations in the squalene epoxidase gene
- (2018) Ashutosh Singh et al. MYCOSES
- Severe dermatophytosis in solid organ transplant recipients: A French retrospective series and literature review
- (2018) Claire Rouzaud et al. Transplant Infectious Disease
- Discovery of Terbinafine Low Susceptibility Trichophyton rubrum strain in Japan
- (2018) SHUSAKU SUZUKI et al. BIOCONTROL SCIENCE
- Correlation of In Vitro Susceptibility Based on MICs and Squalene Epoxidase Mutations with Clinical Response to Terbinafine in Patients with Tinea Corporis/Cruris
- (2018) Ananta Khurana et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- EUCAST technical note on isavuconazole breakpoints for Aspergillus, itraconazole breakpoints for Candida and updates for the antifungal susceptibility testing method documents
- (2016) M.C. Arendrup et al. CLINICAL MICROBIOLOGY AND INFECTION
- Successful Treatment of Refractory Majocchi’s Granuloma with Voriconazole and Review of Published Literature
- (2015) H. B. Liu et al. MYCOPATHOLOGIA
- Molecular characterization andin vitroantifungal susceptibility of 80 clinical isolates of mucormycetes in Delhi, India
- (2014) Anuradha Chowdhary et al. MYCOSES
- Epidemiological Cutoff Values for Azoles and Aspergillus fumigatus Based on a Novel Mathematical Approach Incorporatingcyp51ASequence Analysis
- (2012) J. Meletiadis et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation